Implementation of an epidemiological surveillance strategy for COVID-19 focused on groups at high risk of SARS-CoV-2 infection

Autores
Esandi, María del Carmen; Marinovich, Joel; Bergé, Ignacio; García, Nicolás Ariel; German, Olga Lorena; Ayala Peña, Victoria Belen; Sierra, Fermín; Serralunga, María Gabriela; Esandi, Maria Eugenia; del Valle, Marta; Bouzat, Cecilia Beatriz
Año de publicación
2021
Idioma
inglés
Tipo de recurso
documento de conferencia
Estado
versión publicada
Descripción
The COVID-19 pandemic has been a challenge to implement strategies to mitigate the transmission of the SARS-CoV-2 virus. Asymptomatic transmission among healthcare workers (HCWs) at the front line of care is particularly concerning due to the potential emergence of outbreaks at healthcare centers. With the final goal of early identification and isolation of asymptomatic infected HCWs, we validated a pooled-sample screening and assessed implementation outcomes and results of an epidemiological surveillance strategy carried out during a 12-month period at public health institutions in Bahía Blanca. To develop and validate a coronavirus detection method, RNA was extracted from nasopharyngeal swabs and iden- tification of the viral E gene was done by an “in-house” RT-qPCR using Taqman probes and the human gene RNAseP as a control. Validation against a commercial kit demonstrated high sensibility and specificity of our test (95%, IC 95%: [85%-100%]). To increase our testing capacity, we validated sample pooling (n= 5) prior to RNA extraction. The results showed a sensibility of 73% (IC 95%: [46%- 99%]) and specificity of 100% against individuals. A tailor-made soft- ware called “VIGI-COVID” was designed to properly manage data. A prospective cohort study was conducted since 15/09/20 to 15/09/21. 860 HCWs were included in the epidemiological surveillance and 1765 swabs were performed. The annual cumulative incidence was 2,30% IC95% [1,26% - 3,39%] (20/860), and 43% of the 860 HCWs were swabbed more than once. Our study demonstrated the utili- ty of comprehensive screening of asymptomatic HCWs during the COVID19 pandemic. Early identification and isolation of infected HCWs prevent the onward transmission of SARS-CoV-2, reducing the risk of healthcare-associated outbreaks.
Fil: Esandi, María del Carmen. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
Fil: Marinovich, Joel. Hospital Municipal Doctor Leónidas Lucero; Argentina
Fil: Bergé, Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
Fil: García, Nicolás Ariel. Universidad Nacional del Sur. Departamento de Física; Argentina
Fil: German, Olga Lorena. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
Fil: Ayala Peña, Victoria Belen. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
Fil: Sierra, Fermín. Hospital Municipal Doctor Leónidas Lucero; Argentina
Fil: Serralunga, María Gabriela. Universidad Nacional del Sur; Argentina
Fil: Esandi, Maria Eugenia. Universidad Nacional del Sur. Departamento de Economía; Argentina
Fil: del Valle, Marta. Hospital Municipal Doctor Leónidas Lucero; Argentina
Fil: Bouzat, Cecilia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
Reunión anual de las Sociedades de Biociencia: LXVI Reunión anual de la Sociedad Argentina de Investigación Clínica; LXIX Reunión anual de la Sociedad Argentina de Immunología; LIII Reunión anual de la Asociación Argentina de Farmacología Experimental y XI Reunión anual de la Asociación Argentina de Nanomedicinas
Reunión Virtual
Argentina
Sociedad Argentina de Investigación Clínica
Asociación Argentina de Farmacología Experimental
Asociación Argentina de Nanomedicinas
Asociación Argentina de Nanomedicinas
Materia
pandemia
screening
PCR
Sars-CoV2
COVID-19
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/184785

id CONICETDig_4e97e501c4bb89c39137a5ac58f610da
oai_identifier_str oai:ri.conicet.gov.ar:11336/184785
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Implementation of an epidemiological surveillance strategy for COVID-19 focused on groups at high risk of SARS-CoV-2 infectionEsandi, María del CarmenMarinovich, JoelBergé, IgnacioGarcía, Nicolás ArielGerman, Olga LorenaAyala Peña, Victoria BelenSierra, FermínSerralunga, María GabrielaEsandi, Maria Eugeniadel Valle, MartaBouzat, Cecilia BeatrizpandemiascreeningPCRSars-CoV2COVID-19https://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1The COVID-19 pandemic has been a challenge to implement strategies to mitigate the transmission of the SARS-CoV-2 virus. Asymptomatic transmission among healthcare workers (HCWs) at the front line of care is particularly concerning due to the potential emergence of outbreaks at healthcare centers. With the final goal of early identification and isolation of asymptomatic infected HCWs, we validated a pooled-sample screening and assessed implementation outcomes and results of an epidemiological surveillance strategy carried out during a 12-month period at public health institutions in Bahía Blanca. To develop and validate a coronavirus detection method, RNA was extracted from nasopharyngeal swabs and iden- tification of the viral E gene was done by an “in-house” RT-qPCR using Taqman probes and the human gene RNAseP as a control. Validation against a commercial kit demonstrated high sensibility and specificity of our test (95%, IC 95%: [85%-100%]). To increase our testing capacity, we validated sample pooling (n= 5) prior to RNA extraction. The results showed a sensibility of 73% (IC 95%: [46%- 99%]) and specificity of 100% against individuals. A tailor-made soft- ware called “VIGI-COVID” was designed to properly manage data. A prospective cohort study was conducted since 15/09/20 to 15/09/21. 860 HCWs were included in the epidemiological surveillance and 1765 swabs were performed. The annual cumulative incidence was 2,30% IC95% [1,26% - 3,39%] (20/860), and 43% of the 860 HCWs were swabbed more than once. Our study demonstrated the utili- ty of comprehensive screening of asymptomatic HCWs during the COVID19 pandemic. Early identification and isolation of infected HCWs prevent the onward transmission of SARS-CoV-2, reducing the risk of healthcare-associated outbreaks.Fil: Esandi, María del Carmen. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; ArgentinaFil: Marinovich, Joel. Hospital Municipal Doctor Leónidas Lucero; ArgentinaFil: Bergé, Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; ArgentinaFil: García, Nicolás Ariel. Universidad Nacional del Sur. Departamento de Física; ArgentinaFil: German, Olga Lorena. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; ArgentinaFil: Ayala Peña, Victoria Belen. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; ArgentinaFil: Sierra, Fermín. Hospital Municipal Doctor Leónidas Lucero; ArgentinaFil: Serralunga, María Gabriela. Universidad Nacional del Sur; ArgentinaFil: Esandi, Maria Eugenia. Universidad Nacional del Sur. Departamento de Economía; ArgentinaFil: del Valle, Marta. Hospital Municipal Doctor Leónidas Lucero; ArgentinaFil: Bouzat, Cecilia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; ArgentinaReunión anual de las Sociedades de Biociencia: LXVI Reunión anual de la Sociedad Argentina de Investigación Clínica; LXIX Reunión anual de la Sociedad Argentina de Immunología; LIII Reunión anual de la Asociación Argentina de Farmacología Experimental y XI Reunión anual de la Asociación Argentina de NanomedicinasReunión VirtualArgentinaSociedad Argentina de Investigación ClínicaAsociación Argentina de Farmacología ExperimentalAsociación Argentina de NanomedicinasAsociación Argentina de NanomedicinasFundación Revista Medicina2021info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónJournalhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/184785Implementation of an epidemiological surveillance strategy for COVID-19 focused on groups at high risk of SARS-CoV-2 infection; Reunión anual de las Sociedades de Biociencia: LXVI Reunión anual de la Sociedad Argentina de Investigación Clínica; LXIX Reunión anual de la Sociedad Argentina de Immunología; LIII Reunión anual de la Asociación Argentina de Farmacología Experimental y XI Reunión anual de la Asociación Argentina de Nanomedicinas; Reunión Virtual; Argentina; 2021; 117-1171669-9106CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.saic.org.ar/revista-medicinaNacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:55:07Zoai:ri.conicet.gov.ar:11336/184785instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:55:07.449CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Implementation of an epidemiological surveillance strategy for COVID-19 focused on groups at high risk of SARS-CoV-2 infection
title Implementation of an epidemiological surveillance strategy for COVID-19 focused on groups at high risk of SARS-CoV-2 infection
spellingShingle Implementation of an epidemiological surveillance strategy for COVID-19 focused on groups at high risk of SARS-CoV-2 infection
Esandi, María del Carmen
pandemia
screening
PCR
Sars-CoV2
COVID-19
title_short Implementation of an epidemiological surveillance strategy for COVID-19 focused on groups at high risk of SARS-CoV-2 infection
title_full Implementation of an epidemiological surveillance strategy for COVID-19 focused on groups at high risk of SARS-CoV-2 infection
title_fullStr Implementation of an epidemiological surveillance strategy for COVID-19 focused on groups at high risk of SARS-CoV-2 infection
title_full_unstemmed Implementation of an epidemiological surveillance strategy for COVID-19 focused on groups at high risk of SARS-CoV-2 infection
title_sort Implementation of an epidemiological surveillance strategy for COVID-19 focused on groups at high risk of SARS-CoV-2 infection
dc.creator.none.fl_str_mv Esandi, María del Carmen
Marinovich, Joel
Bergé, Ignacio
García, Nicolás Ariel
German, Olga Lorena
Ayala Peña, Victoria Belen
Sierra, Fermín
Serralunga, María Gabriela
Esandi, Maria Eugenia
del Valle, Marta
Bouzat, Cecilia Beatriz
author Esandi, María del Carmen
author_facet Esandi, María del Carmen
Marinovich, Joel
Bergé, Ignacio
García, Nicolás Ariel
German, Olga Lorena
Ayala Peña, Victoria Belen
Sierra, Fermín
Serralunga, María Gabriela
Esandi, Maria Eugenia
del Valle, Marta
Bouzat, Cecilia Beatriz
author_role author
author2 Marinovich, Joel
Bergé, Ignacio
García, Nicolás Ariel
German, Olga Lorena
Ayala Peña, Victoria Belen
Sierra, Fermín
Serralunga, María Gabriela
Esandi, Maria Eugenia
del Valle, Marta
Bouzat, Cecilia Beatriz
author2_role author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv pandemia
screening
PCR
Sars-CoV2
COVID-19
topic pandemia
screening
PCR
Sars-CoV2
COVID-19
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv The COVID-19 pandemic has been a challenge to implement strategies to mitigate the transmission of the SARS-CoV-2 virus. Asymptomatic transmission among healthcare workers (HCWs) at the front line of care is particularly concerning due to the potential emergence of outbreaks at healthcare centers. With the final goal of early identification and isolation of asymptomatic infected HCWs, we validated a pooled-sample screening and assessed implementation outcomes and results of an epidemiological surveillance strategy carried out during a 12-month period at public health institutions in Bahía Blanca. To develop and validate a coronavirus detection method, RNA was extracted from nasopharyngeal swabs and iden- tification of the viral E gene was done by an “in-house” RT-qPCR using Taqman probes and the human gene RNAseP as a control. Validation against a commercial kit demonstrated high sensibility and specificity of our test (95%, IC 95%: [85%-100%]). To increase our testing capacity, we validated sample pooling (n= 5) prior to RNA extraction. The results showed a sensibility of 73% (IC 95%: [46%- 99%]) and specificity of 100% against individuals. A tailor-made soft- ware called “VIGI-COVID” was designed to properly manage data. A prospective cohort study was conducted since 15/09/20 to 15/09/21. 860 HCWs were included in the epidemiological surveillance and 1765 swabs were performed. The annual cumulative incidence was 2,30% IC95% [1,26% - 3,39%] (20/860), and 43% of the 860 HCWs were swabbed more than once. Our study demonstrated the utili- ty of comprehensive screening of asymptomatic HCWs during the COVID19 pandemic. Early identification and isolation of infected HCWs prevent the onward transmission of SARS-CoV-2, reducing the risk of healthcare-associated outbreaks.
Fil: Esandi, María del Carmen. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
Fil: Marinovich, Joel. Hospital Municipal Doctor Leónidas Lucero; Argentina
Fil: Bergé, Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
Fil: García, Nicolás Ariel. Universidad Nacional del Sur. Departamento de Física; Argentina
Fil: German, Olga Lorena. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
Fil: Ayala Peña, Victoria Belen. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
Fil: Sierra, Fermín. Hospital Municipal Doctor Leónidas Lucero; Argentina
Fil: Serralunga, María Gabriela. Universidad Nacional del Sur; Argentina
Fil: Esandi, Maria Eugenia. Universidad Nacional del Sur. Departamento de Economía; Argentina
Fil: del Valle, Marta. Hospital Municipal Doctor Leónidas Lucero; Argentina
Fil: Bouzat, Cecilia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
Reunión anual de las Sociedades de Biociencia: LXVI Reunión anual de la Sociedad Argentina de Investigación Clínica; LXIX Reunión anual de la Sociedad Argentina de Immunología; LIII Reunión anual de la Asociación Argentina de Farmacología Experimental y XI Reunión anual de la Asociación Argentina de Nanomedicinas
Reunión Virtual
Argentina
Sociedad Argentina de Investigación Clínica
Asociación Argentina de Farmacología Experimental
Asociación Argentina de Nanomedicinas
Asociación Argentina de Nanomedicinas
description The COVID-19 pandemic has been a challenge to implement strategies to mitigate the transmission of the SARS-CoV-2 virus. Asymptomatic transmission among healthcare workers (HCWs) at the front line of care is particularly concerning due to the potential emergence of outbreaks at healthcare centers. With the final goal of early identification and isolation of asymptomatic infected HCWs, we validated a pooled-sample screening and assessed implementation outcomes and results of an epidemiological surveillance strategy carried out during a 12-month period at public health institutions in Bahía Blanca. To develop and validate a coronavirus detection method, RNA was extracted from nasopharyngeal swabs and iden- tification of the viral E gene was done by an “in-house” RT-qPCR using Taqman probes and the human gene RNAseP as a control. Validation against a commercial kit demonstrated high sensibility and specificity of our test (95%, IC 95%: [85%-100%]). To increase our testing capacity, we validated sample pooling (n= 5) prior to RNA extraction. The results showed a sensibility of 73% (IC 95%: [46%- 99%]) and specificity of 100% against individuals. A tailor-made soft- ware called “VIGI-COVID” was designed to properly manage data. A prospective cohort study was conducted since 15/09/20 to 15/09/21. 860 HCWs were included in the epidemiological surveillance and 1765 swabs were performed. The annual cumulative incidence was 2,30% IC95% [1,26% - 3,39%] (20/860), and 43% of the 860 HCWs were swabbed more than once. Our study demonstrated the utili- ty of comprehensive screening of asymptomatic HCWs during the COVID19 pandemic. Early identification and isolation of infected HCWs prevent the onward transmission of SARS-CoV-2, reducing the risk of healthcare-associated outbreaks.
publishDate 2021
dc.date.none.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/conferenceObject
Reunión
Journal
http://purl.org/coar/resource_type/c_5794
info:ar-repo/semantics/documentoDeConferencia
status_str publishedVersion
format conferenceObject
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/184785
Implementation of an epidemiological surveillance strategy for COVID-19 focused on groups at high risk of SARS-CoV-2 infection; Reunión anual de las Sociedades de Biociencia: LXVI Reunión anual de la Sociedad Argentina de Investigación Clínica; LXIX Reunión anual de la Sociedad Argentina de Immunología; LIII Reunión anual de la Asociación Argentina de Farmacología Experimental y XI Reunión anual de la Asociación Argentina de Nanomedicinas; Reunión Virtual; Argentina; 2021; 117-117
1669-9106
CONICET Digital
CONICET
url http://hdl.handle.net/11336/184785
identifier_str_mv Implementation of an epidemiological surveillance strategy for COVID-19 focused on groups at high risk of SARS-CoV-2 infection; Reunión anual de las Sociedades de Biociencia: LXVI Reunión anual de la Sociedad Argentina de Investigación Clínica; LXIX Reunión anual de la Sociedad Argentina de Immunología; LIII Reunión anual de la Asociación Argentina de Farmacología Experimental y XI Reunión anual de la Asociación Argentina de Nanomedicinas; Reunión Virtual; Argentina; 2021; 117-117
1669-9106
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.saic.org.ar/revista-medicina
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
application/pdf
application/pdf
dc.coverage.none.fl_str_mv Nacional
dc.publisher.none.fl_str_mv Fundación Revista Medicina
publisher.none.fl_str_mv Fundación Revista Medicina
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613664076726272
score 13.069144